"Major drug discovery" special encourage major varieties of research and development and industrialization

Author: source: xinhua publisher: cloud

        13 the ministry of health, the health, issued a "major drug discovery" science and technology major projects "twelfth five-year" plan of 2014 new grant application guide, proposed the key support has important direction and good integration of the operation mechanism of subject, priority support enterprise led by joint university and scientific research institutions in order to realize the industrialization as the goal of substantial joint application.

        Guide, preferential selection advantage industry backbone enterprises, promote their complete varieties of major research and development and industrialization. The core technology research and development must be combined with product development and platform construction.

        Guide is proposed, in view of the pediatric disease, aging and other serious harm people's health, frequently occurring and commonly-seen diseases among independent initiative or technical transformation conforms to "cultivate major products, meet the demand of important, to solve the key problem" principle requires drug varieties. Among them, chemical medicine including multiple drug-resistant bacteria, broad spectrum antiviral resistance, mental disorders, cardiovascular, and immune, anti-tumor, metabolic diseases, etc. With independent intellectual property rights of new drug targets, new technology, meet the demand of clinical and industrial drug patents expire imitation to innovation, drug candidate relocation; Chinese medicine including multidisciplinary innovation of Chinese medicine, Chinese medicine compound, the effective development of new drugs, registered components of traditional Chinese medicine, Chinese medicine internationalization research, traditional Chinese medicine injection system evaluation and the big drug post-marketing safety evaluation; Biological drugs, new vaccines, including new antibody combined vaccine and vaccine adjuvants, polypeptide, clotting factors, gene therapy and genetic engineering medicine nucleic acid drugs, stem cells, biological similar drugs, etc.

        Ministry recently issued the "major drug discovery" science and technology major projects "twelfth five-year" plan of 2014 new grant application guide, has been clear about the medical innovation in 2014 major projects to declare.

        The guide will be in accordance with the said declaration "cultivation of major products, meet the demand of key, to solve the key problem" principle, concrete declaration for the key, the department of health said should be mainly aimed at the serious harm people's health, independent of frequently occurring and commonly-seen diseases among created or technical renovation to meet the requirements of "triple" drug varieties to declare. In addition, the special will also support has important clinical value in new drug research, outcome research primarily indications registration and individualized treatment research.

        Among them in terms of specific key drug varieties, the guide said that should be main future chemical medicine including multiple drug-resistant bacteria, broad spectrum antiviral resistance, mental disorders, cardiovascular, and immune, anti-tumor, metabolic diseases, etc. With independent intellectual property rights of new drug targets, new technology, and meet the demand of industry of clinical drug patents expire imitation to innovation and the reorientation of candidate drugs.

        In terms of traditional Chinese medicine (TCM), key support object include a multidisciplinary innovation of Chinese medicine, Chinese medicine compound drugs, traditional Chinese medicine injection system evaluation and the big drug post-marketing safety evaluation, etc. In terms of biological drugs, the guide said major varieties including antibodies are antibodies coupling drugs, multi-function, composite, new type of antibody, new vaccines and vaccines and vaccine adjuvants, polypeptide, clotting factors such as genetic engineering drugs, gene therapy and nucleic acid drug, stem cells similar to biological medicine, etc.

        The guide said that medical major projects in the future will follow the principle of enterprise main body, encourage enterprises to lead to declare and integrating advantage resources. Also led the joint will give priority to support the enterprise university and scientific research institutions in order to realize the industrialization as the goal of substantial joint application, advantages and priority in selecting industries backbone enterprises, promote their complete varieties of major research and development and industrialization.

        The original links: http://www.biotech.org.cn/information/105650